Staining characterization by immunohistochemistry of tumor cancer antigen in patients with endometrial cancer

European Journal of Gynaecological Oncology

Volumn 29, Issue 5, 2008, Pages 489-492

  Metindir, J ^a   Dilek, G B ^a   Pak, I ^a  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

CA 125; Endometrial carcinoma; Immunohistochemistry

Indexed keywords

CA 125 ANTIGEN; TUMOR ANTIGEN;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MYOMETRIUM; OVARY METASTASIS; SALPINGOOOPHORECTOMY; TUMOR VOLUME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; MYOMETRIUM; NEOPLASM STAGING;

EID: 54949117884     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kabawat S.E., Bast R.C., Bahn A.K., Welch W.R., Knapp R.C., Colvin R.B.: "Tissue distribution of a coelemic epithelium-related antigen recognized by the monoclonal antibody OC 125". Int. J. Gynecol. Pathol., 1983, 2, 275.
2. Neunteufel W., Breitenecker G.: "CA-125 and CEA in the endometrial mucosa during the menstrual cycle, in atypical hyperplasia and endometrial carcinoma". Cancer Lett., 1989, 48, 77.
3. Podczaski E., Kaminski P., Zaino R.: "CA-125 and CA-19-9 immunolocalization in normal, hyperplastic and carcinomatous endometrium". Cancer, 1993, 71, 2551.
4. Mylonas I., Makovitzky J., Richter D.U., Jeschke U., Briese V., Friese K.: "Immunohistochemical expression of the tumour marker CA-125 in normal, hyperplastic and malignant endometrial tissue". Anticancer Res., 2003, 23, 1075.
5. Bischof P., Schindler A.M., Urner F, Mensi N., Herrmann W.L., Sizonenko P.C.: "Pregnancy-associated plasma protein: concentration in uterine fluid and immunohistochemical localization in the endometrium". Br. J. Obstet. Gynecol., 1984, 91, 863.
6. Zeimet A.G., Muller-Holzner E., Marth C., Daxenbichler G., Dapunt O.: "Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle". Fertil. Steril., 1993, 59, 1028.
7. Weintraub J., Bishof P., Tseng L., Redard M., Vassilakos P.: "CA-125 is an excretory product of human endometrial glands". Biol. Reprod., 1990, 42, 721.
8. News FIGO: "Corpus cancer staging". Int. J. Gynecol. Obstet., 1989, 28, 189.
9. Jhang H., Chaung L., Visintainer P., Ramaswamy G.: "CA-125 levels in the preoperative assessment of advanced-staged uterine cancer". Am. J. Obstet. Gynecol., 2003, 188, 1195.
10. Silverberg S.G., Kurman R.J., Nogales F.: "Tumours of the uterine corpus". In: Tavassoli F.A., Devilee P. (eds.), World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, IARC Press, 2003, 221.
11. Remmele W., Schicketanz K.H.: "Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS)". Pathol. Res. Pract., 1993, 189, 862.
12. Fedele L., Vercellini P., Arcaini L., da Dalt MG., Candiani GB.: "CA-125 in serum, peritoneal fluid, active lesions and endometrium of patients of endometriosis". Am. J. Obstet. Gynecol., 1988, 158, 166.
13. Berchuck A., Soisson A.P., Clarke-Pearson D.L., Soper J.T., Boyer C.M., Kinney R.B., McCarty K.S. Jr., Bast R.C. Jr.: "Immunohistochemical expression of CA-125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential"., Cancer Res., 1989, 49, 2091.
14. Nur S., Chuang L., Ramaswamy G.: "Immunohistochemical characterization of cancer antigen in uterine cancer". Int. J. Gynecol. Cancer, 2006, 16, 1903.